Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), _ decrease (Expand Search)
a non » _ non (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), _ decrease (Expand Search)
a non » _ non (Expand Search)
-
41
-
42
-
43
-
44
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025“…In the non-recurrence group, CRT improved from 482.5 ± 112.8 to 294.7 ± 65.3, 302.0 ± 68.0, 284.7 ± 55.4, 285.3 ± 70.2, 265.2 ± 65.0, and 266.1 ± 78.2 μm at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g006" target="_blank">Fig 6</a>).…”
-
45
-
46
-
47
Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR.
Published 2024Subjects: -
48
-
49
-
50
-
51
-
52
The <i>P[syt<sup>P-L</sup>]</i> mutation decreases the Ca<sup>2+</sup> affinity of release and vesicular release probability, but the readily releasable pool is unchanged.
Published 2017“…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt<sup>WT</sup>]/+</i> (filled black circles) and <i>+/-;P[syt<sup>P-L</sup>]/+</i> (filled red circles) larvae at Ca<sup>2+</sup> levels ranging from 0.05 mM—5.0 mM. …”
-
53
-
54
-
55
-
56
-
57
-
58
-
59
Treatment with anti-JAM-C antibody decreases the severity of antigen-induced arthritis
Published 2011“…Results shown represent the mean ± SEM for anti-JAM-C antibody-treated (= 5 on day 4, = 6 on day 8, black columns) and isotype-matched control antibody-treated (= 5 at both time points, open columns) mice. …”
-
60